Results 231 to 240 of about 5,808 (257)

LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager

Frontiers in Immunology, 2022
Michael Bergmann, Bergmann Michael
exaly  

Design of a Trispecific Checkpoint Inhibitor and Natural Killer Cell Engager Based on a 2 + 1 Common Light Chain Antibody Architecture

Frontiers in Immunology, 2021
Harald Kolmar, Julius Grzeschik, Björn Hock   +2 more
exaly  

Tumor and T cell engagement by BiTE.

Discovery medicine, 2014
Cancer immunotherapy attempts to exploit the capability of the immune system to attack malignant cells. Recent results suggest that clinical responses in patients point to this new mechanism as potentially beneficial in harnessing the immune system for combating established malignancies.
openaire   +1 more source

Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy

Frontiers in Immunology, 2023
Wolfgang Loidl, Horst-Dieter Hummel, Daniel T Mytych   +2 more
exaly  

Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy

Frontiers in Immunology, 2023
Arash Hatefi, Ge Yang, Hatefi Arash
exaly  

T-cell engagers in rheumatology

Best Practice & Research Clinical Rheumatology
Alberto Nordmann-Gomes, Leila Khalili, Stephen Wax, Anca Askanase   +3 more
openaire   +1 more source

Derivation and Preclinical Characterization of CYT-303, a Novel NKp46-NK Cell Engager Targeting GPC3

Cells, 2023
Armand Bensussan, Martine Cerutti, Mandelboim Ofer   +2 more
exaly  

A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells

Cancers, 2022
Domenico Britti, Daniele Caracciolo, Mariamena Arbitrio   +2 more
exaly  

T-cell engager antibodies enable T cells to control HBV infection and to target HBsAg-positive hepatoma in mice

Journal of Hepatology, 2021
Fazel Shokri, Chunkyu Ko, Forough Golsaz-Shirazi   +2 more
exaly  

Oncolytic vaccinia virus expressing a bispecific T-cell engager enhances immune responses in EpCAM positive solid tumors

Frontiers in Immunology, 2022
Jiwu Wei, Lingkai Kong, Kong Lingkai
exaly